<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34690357</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1578-1860</ISSN><JournalIssue CitedMedium="Internet"><Volume>222</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Revista clinica espanola</Title><ISOAbbreviation>Rev Clin Esp</ISOAbbreviation></Journal><ArticleTitle>[Beyond acute SARS-CoV-2 infection: A new challenge for Internal Medicine].</ArticleTitle><Pagination><StartPage>176</StartPage><EndPage>179</EndPage><MedlinePgn>176-179</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.rce.2021.09.005</ELocationID><Abstract><AbstractText>Infection with the new SARS-CoV-2 coronavirus has reached pandemic proportions, with a very high death toll worldwide. Despite the scientific community's strenuous efforts to address this disease in its acute phase, as well as in prevention through the development of vaccines in record time, there remains another important workhorse: understanding and treating the persistence of symptoms beyond the acute phase, the so-called protracted COVID-19 syndrome or persistent COVID. These persistent manifestations affect several organs and systems and may depend on both the pathogenic mechanisms of the virus and the pathophysiological response of the patient. One year after the onset of this pandemic, there is an urgent need to address this situation from a comprehensive approach.</AbstractText><CopyrightInformation>&#xa9; 2021 Elsevier Espa&#xf1;a, S.L.U. and Sociedad Espa&#xf1;ola de Medicina Interna (SEMI). All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mart&#xed;n-Garrido</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Interna, Hospital Universitario Virgen del Roc&#xed;o, Sevilla, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Medrano-Ortega</LastName><ForeName>F J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Interna, Hospital Universitario Virgen del Roc&#xed;o, Sevilla, Espa&#xf1;a.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Roc&#xed;o/CSIC/Universidad de Sevilla y CIBERESP, Sevilla, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>M&#xe1;s all&#xe1; de la infecci&#xf3;n aguda por SARS-CoV-2: un nuevo desaf&#xed;o para la Medicina Interna.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Rev Clin Esp</MedlineTA><NlmUniqueID>8608576</NlmUniqueID><ISSNLinking>0014-2565</ISSNLinking></MedlineJournalInfo><OtherAbstract Type="Publisher" Language="spa"><AbstractText>La infecci&#xf3;n por el nuevo coronavirus SARS-CoV-2 ha alcanzado proporciones de pandemia, con un n&#xfa;mero de muertes muy elevado en todo el mundo. A pesar del esfuerzo &#xed;mprobo desarrollado por la comunidad cient&#xed;fica para abordar esta enfermedad en su fase aguda, as&#xed; como en la prevenci&#xf3;n mediante la creaci&#xf3;n de vacunas en tiempo r&#xe9;cord, a&#xfa;n queda otro caballo de batalla importante: comprender y tratar la persistencia de s&#xed;ntomas m&#xe1;s all&#xe1; de la fase aguda, el llamado &#xab;s&#xed;ndrome COVID-19 prolongado&#xbb; o &#xab;COVID persistente&#xbb;. Estas manifestaciones persistentes afectan a varios &#xf3;rganos y sistemas y podr&#xed;an depender tanto de los mecanismos patog&#xe9;nicos del virus como de la respuesta fisiopatol&#xf3;gica del paciente. Un a&#xf1;o despu&#xe9;s del inicio de esta pandemia es una necesidad urgente abordar esta situaci&#xf3;n desde un enfoque integral.</AbstractText><CopyrightInformation>&#xa9; 2021 Elsevier Espa&#xf1;a, S.L.U. and Sociedad Espa&#xf1;ola de Medicina Interna (SEMI). All rights reserved.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Long COVID haulers</Keyword><Keyword MajorTopicYN="N">Post-COVID syndrome</Keyword><Keyword MajorTopicYN="N">Post-acute COVID-19</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>26</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>10</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34690357</ArticleId><ArticleId IdType="pmc">PMC8520883</ArticleId><ArticleId IdType="doi">10.1016/j.rce.2021.09.005</ArticleId><ArticleId IdType="pii">S0014-2565(21)00184-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ritchie H, Ortiz-Ospina E, Beltekian D, Mathieu E, Hasell J, Macdonald B, et al. Coronavirus Pandemic (COVID-19), OurWorldInData.org [consultado 8 May 2021]. Disponible en: https://ourworldindata.org/coronavirus</Citation></Reference><Reference><Citation>World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard [consultado 8 May 2021]. Disponible en: https://covid19.who.int/</Citation></Reference><Reference><Citation>National Institute for Health and Care Excellence. COVID-19 rapid guideline: Managing the long-term effects of COVID-19. Disponible en: https://www.nice.org.uk/guidance/ng188/resources/covid19-rapid-guideline-managing-thelongterm-effects-of-covid19-pdf-66142028400325</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Sociedad Espa&#xf1;ola de M&#xe9;dicos Generales y de Familia. COVID-19 persistente. Encuesta [consultado 30 Abr 2021]. Disponible en: https://www.semg.es/images/2020/Noticias/20201111_Resultados_Encuesta_COVID Persistente.pdf</Citation></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, Cheng V, Dagens D, Hastie C, et al. Characterising long-term COVID-19: A rapid living systematic review. medRxiv preprint [consultado 8 May 2021]. Disponible en: https://doi.org/10.1101/2020.12.08.20246025</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda E, Rebolledo PA, Cuapio A, et al. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. medRxiv [consultado 8 May 2021]. Disponible en: https://doi.org/10.1101/2021.01.27.21250617</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldofsky H., Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011;11:37. doi: 10.1186/1471-2377-11-37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-11-37</ArticleId><ArticleId IdType="pmc">PMC3071317</ArticleId><ArticleId IdType="pubmed">21435231</ArticleId></ArticleIdList></Reference><Reference><Citation>Herridge MS, Cheung AM, Tansey CM, Matte-Martyn A, Diaz-Granados N, Al-Saidi F, et al., Canadian Critical Care Trials Group. One-year outcomes in survivors of the acute respiratory distress syndrome.N Engl J Med. 2003 Feb 20;348:683-93. doi: 10.1056/NEJMoa022450</Citation><ArticleIdList><ArticleId IdType="pubmed">12594312</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics, United Kingdom. The prevalence of long COVID symptoms and COVID-19 complications [consultado 8 May 2021]. Disponible en: https://www.ons.gov.uk/news/statementsandletters/theprevalenceoflongcovidsymptomsandcovid19complications</Citation></Reference><Reference><Citation>Dennis A, Wamil M, Kapur S, Alberts J, Badley A, Decker GA, et al. Multi-organ impairment in low-risk individuals with long COVID. medRxiv. Disponible en: https://doi.org/10.1101/2020.10.14.20212555</Citation></Reference><Reference><Citation>British Society for Immunology. Long-term immunological health consequences of COVID-19, 2021 [consultado 8 May 2021]. Disponible en: https://www.immunology.org/sites/default/files/BSI_Briefing_Note_August_2020_FINAL.pdf</Citation></Reference><Reference><Citation>Gaebler C., Wang Z., Lorenzi J.C.C., Finkin S., Tokuyama M., Cho A., et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591:639&#x2013;644. doi: 10.1038/s41586-021-03207-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03207-w</ArticleId><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang EY, Mao T, Klein J, Dai Y, Huck J D, Liu F, et al. Diverse Functional Autoantibodies in patients with COVID-19. medRxiv. Disponible en: https://doi.org/10.1101/2020.12.10.20247205</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Meeting the challenge of long COVID Nat Med. 2020;26:1803. Disponible en: https://doi.org/10.1038/s41591-020-01177-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">33288947</ArticleId></ArticleIdList></Reference><Reference><Citation>Barquilla-Garc&#xed;a A, del Corral E, D&#xed;az-Pedroche C, Lumbreras-Bermejo C, Mart&#xed;n-S&#xe1;nchez V, Moran-Bay&#xf3;n A, et al. Protocolo para la continuidad asistencial del paciente con diagn&#xf3;stico de COVID19. Disponible en: https://www.fesemi.org/sites/default/files/documentos/776.pdf</Citation></Reference><Reference><Citation>Sociedad Espa&#xf1;ola de directivos de la salud. Documento para la atenci&#xf3;n integral al paciente post-COVID. Disponible en; https://sedisa.net/wp-content/uploads/2020/10/DocumentoAtencionIntegralPost-Covid.pdf</Citation></Reference><Reference><Citation>Gu&#xed;a cl&#xed;nica para la atenci&#xf3;n al paciente Long COVID/COVID persistente. Disponible en; https://www.semg.es/images/2021/Documentos/GUIA_CLINICA_COVID_Persistent_20210501_version_final.pdf</Citation></Reference><Reference><Citation>Sis&#xf3;-Almirall A. Manifestaciones persistentes de la COVID-19. Gu&#xed;a de Pr&#xe1;ctica Cl&#xed;nica. Societat Catalana de Medicina Familiar i Comunit&#xe0;ria (CAMFiC). ISBN: 978-84-121938-5-5</Citation></Reference><Reference><Citation>Sociedad Espa&#xf1;ola de Medicina Interna. Registro SEMI COVID-19. Disponible en: https://www.fesemi.org/investigacion/proyectos/registro-semi-covid-19</Citation></Reference><Reference><Citation>Bianchi-Llave J.L., Mart&#xed;n-Escalante M.D., Calder&#xf3;n-Sandubete E.J. La Medicina Interna ante las crisis sanitarias. Actual Med. 2020;105:135&#x2013;136.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>